Edition:
United States

Justin George Varghese

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

4:29am EDT

Britain's Spire rejects 1.2 billion pound Mediclinic offer, shares soar

Britain's Spire Healthcare has rejected a full takeover offer from South African private hospitals operator Mediclinic International , which already owns nearly 30 percent of its stock, sending its shares up 12 percent.

Oct 16 2017

ConvaTec slashes revenue growth outlook, shares slump

Medical technology company ConvaTec Group Plc on Monday slashed its full-year organic revenue growth forecast after supply issues hurt its third quarter, wiping off a fifth of its market value.

Sep 22 2017

Smiths Group's core revenue slips, shares drop

British conglomerate Smiths Group reported a fall in underlying full-year revenue due to weakness in its energy equipment and service business as well as its medical device unit.

Sep 20 2017

Mitie may cut 480 jobs, raises clean-up costs

British outsourcing company Mitie Group may cut up to 480 jobs as it overhauls its cleaning and engineering divisions, and said the cost of its turnaround would be higher than expected.

Sep 15 2017

Indivior files lawsuits against Suboxone generic rivals

Indivior's U.S. subsidiary has filed lawsuits against firms seeking approval for generic versions of its opioid addiction treatment Suboxone, which generates 80 percent of the drugmaker's revenue.

Sep 14 2017

Spire Healthcare profit slumps, outlook muted; shares plunge

Spire Healthcare Group Plc , Britain's second-largest healthcare firm, said first-half profit slumped 75 percent, hurt by legal settlement charges, sending its shares down as much as 25 percent on Thursday morning.

Sep 06 2017

Drugmaker Vectura warns of destocking hit, shares slide

British drugmaker Vectura reported a doubling in first-half losses and warned full-year revenues would be hit by customers running down stocks of asthma inhaler Flutiform, sending its shares as much as 14 percent lower on Wednesday.

Sep 01 2017

London-listed drugmaker Indivior shares crash after U.S. patent blow

Shares in London-listed Indivior plunged 40 percent after the drugmaker said a U.S. court ruling could clear the way for a generic rival to its treatment for opioid addiction that generates 80 percent of its revenues.

Aug 31 2017

BAT restructures to help e-cigarettes go mainstream

British American Tobacco has reorganized its regional management structure to integrate its vaping products with its core business, in a push by the world’s biggest listed tobacco company to help cigarette alternatives go mainstream.

Aug 25 2017

Computacenter to return 100 million pounds in fourth quarter, shares soar to 17-year high

IT services provider Computacenter said it would return 100 million pounds to shareholders in the fourth quarter, following a 15 percent rise in first-half revenue on favourable currency impact, strong growth in Germany and recovery in the United Kingdom.

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary